B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme	Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder	Recruiting	Phase 1	2026-09-15		NCT05474378

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
California Institute for Regenerative Medicine (CIRM)	36
Parker Institute for Cancer Immunotherapy	4
Stanford University	620

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Stanford Cancer Institute	Palo Alto	United States	11

Clinical trials